Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer-Reference-Cited by-同舟云学术

Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer

Published:2020-06 Issue:6 Volume:77 Page:701-710
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Necchi Andrea^ORCID,Raggi Daniele,Gallina Andrea,Ross Jeffrey S.,Farè Elena,Giannatempo Patrizia,Marandino Laura,Colecchia Maurizio,Lucianò Roberta,Bianchi Marco,Colombo Renzo,Salonia Andrea,Gandaglia Giorgio,Fossati Nicola,Bandini Marco,Pederzoli Filippo^ORCID,Capitanio Umberto,Montorsi Francesco,de Jong Joep J.,Dittamore Ryan^ORCID,Liu Yang,Davicioni Elai,Boormans Joost L.,Briganti Alberto,Black Peter C.,Gibb Ewan A.

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Role of checkpoint inhibition in localized bladder cancer;Hahn;Eur Urol Oncol,2018

2. Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study;Necchi;J Clin Oncol,2018

3. Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies;Necchi;Eur Urol,2020

4. Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial;Powles;Nat Med,2019

5. Preoperative ipilimumab and nivolumab in locoregionally advanced, stage III, urothelial cancer;van der Hejiden;Ann Oncol,2019

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers;Urologic Oncology: Seminars and Original Investigations;2024-06

2. Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer;European Urology Oncology;2024-06

3. In silico identification and targeting of key genes involved in renal cell carcinoma metastasis;Biomedical Letters;2024-05-25

4. Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy;2024-05-02

5. Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer;European Urology Oncology;2024-05